Educational reference material on Korean skincare ingredients and clinical categories. Written for clinicians, distributors, B2B buyers, and informed readers who want the mechanism and evidence, not marketing copy.
What polydeoxyribonucleotide actually is, how topical and injectable formats differ, what Korean dermatology uses it for, and what the clinical research shows.
What exosomes really are, why topical exosomes differ from injectable exosome therapy, the FDA regulatory status, and what the evidence actually supports.
How clinical-tier Korean skincare actually differs from mass-market K-beauty — concentrations, regulatory tiers, distribution channels, and what 'clinic dispensary' means.